Olga Lytvynova

Olga Lytvynova

Auto-generated profile, based on publicly available information

Olga Lytvynova

National University of Pharmacy, Kharkiv

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2019 in Arterial Hypertension
Verified
Journal Article
Open access
PDF file
SKSergiy M. Koval
Sergiy M. Koval
KYKostiantyn O. Yushko
Kostiantyn O. Yushko
ISIryna O. Snihurska
Iryna O. Snihurska
TSTetyana G. Starchenko
Tetyana G. Starchenko
VPVolodymyr Pankiv
Volodymyr Pankiv
OMOlga V. Mysnychenko
Olga V. Mysnychenko
Background. The angiotensin-(1-7) is a new component of the renin-angiotensin system, the product of the degradation of angiotensin II and its functional antagonist, but its role in hypertension with type 2 diabetes (T2D) is not clear. The aim of the study was to investigate the levels of angiotensin-(1-7) in patients with hypertension and T2D and determine its relations to hemodynamic and cardiac structural and functional parameters. Material and methods. We examined 70 patients with hypertension and T2D. Investigation protocol included physical examination, standard transthoracic echocardiography and determination of the angiotensin-(1-7) blood levels by ELISA. Control group consisted of 16 healthy volunteers. Results. The angiotensin-(1-7) levels in observed patients were significantly lower than in volunteers [105.51 (89.13;121.17) ng/L vs. 132.75 (125.06; 142.87) ng/L, p < 0.001]. The levels of the angiotensin-(1-7) significantly negatively correlated with duration of hypertension (r = –0.29, p < 0.05), systolic blood pressure (BP) (r = –0.38, p < 0.05), diastolic BP (r = –0.36, p < 0.01), average BP (r = –0.32, p < 0.01), left ventricular (LV) internal dimension at end-diastole (r = –0.37, p < 0.01), LV mass (r = –0.40, p < 0.001), LV mass index (r = –0.41, p < 0.001). In patients with LV hypertrophy, angiotensin-(1-7) levels were significantly lower than in patients without LV hypertrophy [101.9 (88.2; 117.7) ng/L vs. 129.3 (117.5; 136.8) ng/L, p < 0.01] and in patients with diastolic LV dysfunction — lower than in the patients with normal diastolic function [101.1 (87.9; 116.6) ng/L vs. 121.1 (105.5; 128.9) ng/L, p < 0.01]. Conclusions. The angiotensin-(1-7) can be considered as an important pathogenetic factor in the development of hypertension with T2D, a BP regulator and a cardioprotective agent that prevents the development of remodeling and diastolic dysfunction of the LV. Background. The angiotensin-(1-7) is a new component of the renin-angiotensin system, the product of the degradation of angiotensin II and its functional antagonist, but its role in hypertension with type 2 diabetes (T2D) is not clear. The aim of the study was to investigate the levels of angiotensin-(1-7) in patients with hypertension and T2D and determine its relations to hemodynamic and cardiac structural and functional parameters. Material and methods. We examined 70 patients with hypertension and T2D. Investigation protocol included physical examination, standard transthoracic echocardiography and determination of the angiotensin-(1-7) blood levels by ELISA. Control group consisted of 16 healthy volunteers. Results. The angiotensin-(1-7) levels in observed patients were significantly lower than in volunteers [105.51 (89.13;121.17) ng/L vs. 132.75 (125.06; 142.87) ng/L, p < 0.001]. The levels of the angiotensin-(1-7) significantly negatively correlated with duration of hypertension (r = –0.29, p < 0.05), systolic blood pressure (BP) (r = –0.38, p < 0.05), diastolic BP (r = –0.36, p < 0.01), average BP (r = –0.32, p < 0.01), left ventricular (LV) internal dimension at end-diastole (r = –0.37, p < 0.01), LV mass (r = –0.40, p < 0.001), LV mass index (r = –0.41, p < 0.001). In patients with LV hypertrophy, angiotensin-(1-7) levels were significantly lower than in patients without LV hypertrophy [101.9 (88.2; 117.7) ng/L vs. 129.3 (117.5; 136.8) ng/L, p < 0.01] and in patients with diastolic LV dysfunction — lower than in the patients with normal diastolic function [101.1 (87.9; 116.6) ng/L vs. 121.1 (105.5; 128.9) ng/L, p < 0.01]. Conclusions. The angiotensin-(1-7) can be considered as an important pathogenetic factor in the development of hypertension with T2D, a BP regulator and a cardioprotective agent that prevents the development of remodeling and diastolic dysfunction of the LV.

22 November 2019 in Biomedical Research and Therapy
Verified
Journal Article
Open access
PDF file
SKSergiy M. Koval
Sergiy M. Koval
ISIryna O. Snihurska
Iryna O. Snihurska
TSTetyana G. Starchenko
Tetyana G. Starchenko
MPMarina Yu. Penkova
Marina Yu. Penkova
OMOlga V. Mysnychenko
Olga V. Mysnychenko
Alexander E. BerezinAlexander E. Berezin
Alexander E. Berezin
Background: Arterial hypertension (AH) remains the most common cardiovascular (CV) risk factor worldwide. Methods: Seventy five moderate-to-severe hypertensive patients with abdominal obesity aged from 48 to 66 years (45/30 men and women respectively) were selected from the entire cohort (n = 375) according to the inclusion and exclusion criteria. The patients were divided into two subgroups depending on the arm of antihypertensive therapy lines. The first subgroup of patients (n = 36) received a non-fixed combination of oral antihypertensive agents: perindopril (4–8 mg daily), indapamide (1.25–2.5 mg daily) and amlodopine (5–10 mg daily). The second subgroup of patients (n=39) received fixed-dosed combination of these antihypertensive agents aforementioned in the ranged doses (4 mg/1.25mg/5 mg; 4 mg/1.25mg/10 mg; 8 mg/2.5 mg/5 mg; 8 mg/2.5mg/10 mg) in the same manner. The examinations of the clinical status, office, and ambulatory blood pressure values were carried out at baseline in 3 and 6 months after study entry. Results: The frequencies of BP target levels after treatment were higher in the fixed-dose combination group than in the non-fixed combination (at 3 months: 80% versus 58%, p<0.05 and at 6 months: 85% versus 53%, p<0.05). The adherence to triple fixed-dose combination was also higher in comparison with one to non-fixed combination (at 3 months: 82% versus 64%, p<0.05 and at 6 months: 87% versus 61%, p<0.05). It has been established that low-dose of perindopril/indapamide/amlodopine (4mg/1.25/10mg and 8mg/2.5/5mg) were used frequently in fixed-dose combination cohort of patients than in non-fixed combination (15% versus 0%, P<0.05, and 33% versus 19%, p<0.05, respectively). At the same time, maximum doses of these agents (8mg/2.5mg/10mg) were required for achieving target BP levels in a significantly lower proportion of patients receiving fixed-dose combination as compared to patients receiving non-fixed combination (52% versus 81%, p<0.05). Additionally, the triple fixed-dose combination has proved to be better in restoring ambulatory blood pressure monitoring profile than non-fixed combination. Conclusion: Achievement of target blood pressure levels in patients with uncontrolled arterial hypertension and abdominal obesity was possible at lower doses of perindopril, indapamide, and amlodipine when used as a fixed-dose combination rather than non-fixed (free) combination.

30 September 2023 in ScienceRise: Medical Science
Verified
Journal Article
Open access
PDF file
OMOlena Matviichuk
Olena Matviichuk
RYRymma Yeromenko
Rymma Yeromenko
OLOlga Lytvynova
Olga Lytvynova
ODOlena Dolzhykova
Olena Dolzhykova
AMAnatolii Matviichuk
Anatolii Matviichuk
NLNikolay Lytvynenko
Nikolay Lytvynenko
Water plays a key role in ensuring the social and ecological well-being of the population of any state. At the same time, fresh water as a resource and related water infrastructure are among the most vulnerable sectors during armed conflicts. In this regard, it is relevant to study the impact of the armed conflict on water supply and the water system of Ukraine. The aim of the study was to analyze the impact of military actions on the state of drinking water supply in Ukraine and the Kharkiv region and its potential impact on the state of health of the local population. Materials and methods. Weekly reports of the Ministry of Ecology and Natural Resources of Ukraine, reports of the Ministry of Reintegration of Temporarily Occupied Territories and Internally Displaced Persons of Ukraine, reports of Ukrainian regional military administrations, and a report of the Kharkiv Laboratory Center on the analysis of the state of drinking water supply in the settlements of the Kharkiv region and the city were used as the main source of information. Results. As a result of the conducted analytical research, various types of influence of military operations on the water supply system of Ukraine were revealed. An increase in the level of surface water pollution has been established, in particular due to sunken military facilities and emissions of chemical substances as a result of shelling. Several impacts have been identified as potential threats, including flooding due to damage to dams, threats related to nuclear power plants, incidents of periodic flooding of underground mines, possible detonation of chlorine tanks in the area of wastewater treatment plants, and sea mine explosions in the Danube Delta. The results of the conducted research revealed that the quality of drinking water in the water supply systems of some settlements of Ukraine does not meet the hygienic requirements in terms of bacteriological, sanitary-chemical and radiation indicators. High concentrations of metals and their compounds entering the tissues of the body in the form of an aqueous solution pose a particular danger to the health of the population Conclusion. As a result of Russia's armed aggression, wastewater treatment systems were disrupted, which led to an increase in the pollution of surface water sources

1 May 2019
Verified
Journal Article
Closed access
SKSergiy Koval
Sergiy Koval
ISI Snihurska
I Snihurska
KYKostiantyn Yushko
Kostiantyn Yushko
OLOlga Lytvynova
Olga Lytvynova
Alexander E. BerezinAlexander E. Berezin
Alexander E. Berezin

15 December 2022 in PROBLEMS OF ENDOCRINE PATHOLOGY
Verified
Journal Article
Open access
PDF file
SKSergiy Koval
Sergiy Koval
OMOlga Mysnychenko
Olga Mysnychenko
MPMaryna Penkova
Maryna Penkova
OLOlga Lytvynova
Olga Lytvynova
OBOleksandr Berezin
Oleksandr Berezin
The aim: to study the effectiveness of adding metformin to statin therapy to correct prodiabetogenic changes in patients with arterial hypertension (AH) and abdominal obesity (AO). Materials and methods. We examined 65 patients with 2-3 degrees of AH in combination with AO of I-II degrees, atherogenic dyslipidemia and insulin resistance (IR) aged 47-59 yrs: group 1 – 35 patients who were treated with statins (atorvastatin) against the background of standard combinations of antihypertensive drugs, metformin was added; group 2 – 30 patients who did not receive metformin. The examination included generally accepted methods. Statistical data analysis was carried out using standard methods using Microsoft Excel 7.0 and SPSS 19.0 application packages. Results. The addition of metformin to atorvastatin against the background of standard antihypertensive therapy and recommendations for the normalization of lifestyle allowed a significant reduction in IR and the incidence of prediabetes in hypertensive patients with AO after 16 weeks of treatment. In patients who did not receive metformin, there was no decrease in these indicators. In the group of patients who used metformin, a significantly higher frequency of achieving target blood pressure levels was revealed than in the group of patients in whom this drug was not used. Conclusions. The effectiveness of the use of the insulin sensitizer metformin for the correction of pro-diabetogenic changes associated with statin therapy in patients with AH, which occurs against the background of AO, atherogenic dyslipidemia, and IR, has been shown.

13 February 2019
Verified
Book Chapter
Closed access
PDF file
OVO.V. Vysotska
O.V. Vysotska
YBY.G. Bespalov
Y.G. Bespalov
APA.I. Pecherska
A.I. Pecherska
SKS.M. Koval
S.M. Koval
OLO.M. Lytvynova
O.M. Lytvynova
AKAliya Kalizhanova
Aliya Kalizhanova
The paper presents the results of a study of the systemic aspects of the effect of treatment of patients with Arterial Hypertension (AH) and Abdominal Obesity (AO) on the dynamics of pulse arterial pressure and vascular damage factors using Discrete Dynamic System Models (DDSM). The construction of an idealized system trajectory with the help of DMDS was carried out using an approach based on an extended interpretation of Liebig’s law. The use of the obtained findings in clinical trials can create the prerequisites for developing a new approach to assessing the effectiveness of treatment. It seems reasonable and promising to use DDSM to investigate systemic aspects of the cardiovascular system functioning, in particular in patients with AH in combination with AO, in the dynamics of treatment.